+42.8%
GSK vs RRC
+131.5%
-88.6%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | RRC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.3% | +1.1% | -2.4% | -1.4% |
| 7D | -3.1% | -3.5% | +0.3% | -3.1% |
| 30D | -0.9% | +15.8% | -16.7% | -1.3% |
| 3M | -4.2% | +25.9% | -30.1% | -4.7% |
| 6M | -1.6% | +18.8% | -20.4% | -2.0% |
| YTD | +2.6% | +43.0% | -40.4% | +1.5% |
| 1Y | +6.2% | +29.5% | -23.3% | +5.4% |
| 3Y | +55.0% | +52.9% | +2.1% | +52.3% |
| 5Y | +42.8% | +137.7% | -94.9% | +36.4% |
| All | +42.8% | +131.5% | -88.6% | +36.4% |
Cumulative growth
Daily Returns
Daily percentage return beside RRC.
Daily Out/Under-Performance
Portfolio return minus RRC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RRC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded RRC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling